|
SDF2L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.41310000367767E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.47179999965275E-07 |
| Normal-vs-Stage2 |
9.275500E-02 |
| Normal-vs-Stage3 |
8.967500E-02 |
| Normal-vs-Stage4 |
7.122200E-01 |
| Stage1-vs-Stage2 |
4.371600E-01 |
| Stage1-vs-Stage3 |
3.006800E-01 |
| Stage1-vs-Stage4 |
3.870200E-02 |
| Stage2-vs-Stage3 |
9.127200E-01 |
| Stage2-vs-Stage4 |
1.651360E-01 |
| Stage3-vs-Stage4 |
2.069400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.19080000304805E-08 |
| Normal-vs-AfricanAmerican |
1.050400E-02 |
| Normal-vs-Asian |
1.113990E-01 |
| Caucasian-vs-AfricanAmerican |
1.165440E-01 |
| Caucasian-vs-Asian |
1.961230E-01 |
| AfricanAmerican-vs-Asian |
5.995700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.65929999529757E-08 |
| Normal-vs-Female |
3.568500E-04 |
| Male-vs-Female |
5.667200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.356300E-03 |
| Normal-vs-Extreme_Weight |
1.79479999973253E-07 |
| Normal-vs-Obese |
1.984720E-03 |
| Normal-vs-Extreme_Obese |
1.152760E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.605200E-01 |
| Normal_Weight-vs-Obese |
7.279400E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.057800E-01 |
| Extreme_Weight-vs-Obese |
1.000840E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.593400E-01 |
| Obese-vs-Extreme_Obese |
7.545800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.013170E-01 |
| Normal-vs-Age(41-60Yrs) |
2.22879999999259E-05 |
| Normal-vs-Age(61-80Yrs) |
1.44520000411319E-08 |
| Normal-vs-Age(81-100Yrs) |
8.232400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.084000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.997600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.170400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.560000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.170380E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.973800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.57059928898684E-11 |
| Normal-VS-Type2 PRCC |
1.394380E-02 |
| Normal-VS-KIRP CIMP |
4.158000E-03 |
| Normal-VS-Unclassified PRCC |
4.532300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.164900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
6.19309999999595E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
4.873600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.569500E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
5.204800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.035500E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.98409999999849E-05 |
| Normal-vs-N1 |
5.172800E-01 |
| Normal-vs-N2 |
3.884800E-01 |
| N0-vs-N1 |
3.296400E-02 |
| N0-vs-N2 |
4.964600E-01 |
| N1-vs-N2 |
7.172600E-01 |
|
|